Qiang Wen1, Zhuyan Shao2, Ping Zhang1, Tao Zhu1, Dan Li1, Shihua Wang3. 1. Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China. 2. Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China. Electronic address: zuzuszy@hotmail.com. 3. Department of Cancer Biology, Wake Forest School of Medicine, Winston Salem, USA.
Abstract
BACKGROUND: Anxiety and depression are common sources of mental distress experienced by ovarian cancer patients. The purpose of this study was to identify changes in levels of mental distress during active chemotherapy, to characterize the impact of these changes on quality of life (QOL), and to study the potential buffering effect of social support in recurrent ovarian cancer patients. METHODS: Anxiety and depression were assessed at baseline and three months after initiation of active chemotherapy using hospital anxiety and depression scale (HADS). QOL was evaluated at the same time points using European Organization for Research and Treatment [EORCT] 30-item core quality of life questionnaire (QLQ-C30) and QLQ-OV28. Social support was evaluated by perceived social support scale (PSSS) at baseline. RESULTS: Our results showed recurrent ovarian cancer patients had high rates of anxiety and depression. Levels of anxiety, but not depression, were significantly decreased following active chemotherapy. Notably, both anxiety and depression were significantly associated with poorer QOL on all functioning domains, global health and most symptom domains at both baseline and after chemotherapy. Social support was associated with improved mental state and several functioning and symptom domains of QOL. CONCLUSIONS: Our study reveals a high prevalence of mental distress and its profound detrimental impact on QOL in Chinese women with recurrent ovarian cancer. Social support is beneficial to alleviate mental distress and improve QOL.
BACKGROUND:Anxiety and depression are common sources of mental distress experienced by ovarian cancerpatients. The purpose of this study was to identify changes in levels of mental distress during active chemotherapy, to characterize the impact of these changes on quality of life (QOL), and to study the potential buffering effect of social support in recurrent ovarian cancerpatients. METHODS:Anxiety and depression were assessed at baseline and three months after initiation of active chemotherapy using hospital anxiety and depression scale (HADS). QOL was evaluated at the same time points using European Organization for Research and Treatment [EORCT] 30-item core quality of life questionnaire (QLQ-C30) and QLQ-OV28. Social support was evaluated by perceived social support scale (PSSS) at baseline. RESULTS: Our results showed recurrent ovarian cancerpatients had high rates of anxiety and depression. Levels of anxiety, but not depression, were significantly decreased following active chemotherapy. Notably, both anxiety and depression were significantly associated with poorer QOL on all functioning domains, global health and most symptom domains at both baseline and after chemotherapy. Social support was associated with improved mental state and several functioning and symptom domains of QOL. CONCLUSIONS: Our study reveals a high prevalence of mental distress and its profound detrimental impact on QOL in Chinese women with recurrent ovarian cancer. Social support is beneficial to alleviate mental distress and improve QOL.
Authors: Sharon L Manne; Deborah A Kashy; Shannon Virtue; Kevin R Criswell; David W Kissane; Melissa Ozga; Carolyn J Heckman; Jerod Stapleton; Lorna Rodriguez Journal: Qual Life Res Date: 2018-08-20 Impact factor: 4.147
Authors: Gabriela Ilie; Jillian Bradfield; Louise Moodie; Tarek Lawen; Alzena Ilie; Zeina Lawen; Chloe Blackman; Ryan Gainer; Robert D H Rutledge Journal: Front Oncol Date: 2019-08-20 Impact factor: 6.244
Authors: Belinda Rina Marie Spagnoletti; Linda Rae Bennett; Christina Keenan; Suman Surendra Shetty; Lenore Manderson; Barbara McPake; Siswanto Agus Wilopo Journal: Reprod Health Date: 2022-03-19 Impact factor: 3.223